Is GNBT.OB a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

657 people get GNBT.OB articles and Market Currents by email alert.

Get email alerts on GNBT.OB »

HEADLINES:

Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine

PR Newswire (Wed, 9:00AM)
Generex Comments on Results of Stockholders` Meeting

PR Newswire (Apr 3, 2013)
4 Drug Delivery Companies That Deliver For Investors
Ryan's View • Wed, Feb 27
Generex Biotechnology's CEO Hosts Investor Conference Call (Transcript)
Thu, Jan 31 • 1 Comment
Generex: Research For Sale On The Cheap
Thomas Barnard • Thu, Jan 31 • 24 Comments
Weekly Stock Watch: Week Of July 9
VFC's Stock House • Sun, Jul 8, 2012
Critical Success Factors For The Immunotherapy Race
Andrew J. Norris • Thu, May 17, 2012 • 9 Comments
Breast Cancer Immunotherapy: A New Hope In The Fight
Chemistfrog • Fri, Mar 9, 2012 • 17 Comments
Financing Deals Sent Shares Of These 3 Companies South
VFC's Stock House • Wed, Feb 1, 2012 • 3 Comments
Biopharma Stocks To Watch This Week
VFC's Stock House • Thu, Jan 19, 2012 • 1 Comment
Generex's Antigen Express Makes Progress In Early Stage Breast Cancer
Rich Steffens • Wed, Jan 11, 2012 • 6 Comments
2012 Preview: Cancer Immunotherapy Catalysts
Michael Becker • Thu, Dec 15, 2011 • 20 Comments
Stocks To Watch As Volatility Abounds In Europe
VFC's Stock House • Wed, Nov 16, 2011 • 3 Comments
Mannkind: One To Watch With High Short Interest And Insider Buying
VFC's Stock House • Mon, Nov 14, 2011 • 8 Comments
Weekly Healthcare Stock Watch
VFC's Stock House • Wed, Oct 5, 2011
Generex Corporate Update: The Potential Is There
VFC's Stock House • Thu, Aug 4, 2011 • 5 Comments
Stocks to Watch This Week
VFC's Stock House • Mon, Jun 13, 2011 • 9 Comments
Filling an Unmet Need: A Look at Generex and RXI Pharma's Breast Cancer Vaccines
Rich Steffens • Thu, Jun 2, 2011 • 6 Comments
A Simplified ASCO 2011 List for Biotech Investor Research
Chemistfrog • Mon, May 9, 2011 • 2 Comments
Mannkind/Generex: Both on the Brink of Diabetic Insulin Spray Breakthrough
VFC's Stock House • Fri, May 6, 2011 • 16 Comments

To learn more about Seeking Alpha Pro, click here.

Generex: Research For Sale On The Cheap
Thomas Barnard • Thu, Jan 31 • 24 Comments
Generex's Antigen Express Makes Progress In Early Stage Breast Cancer
Rich Steffens • Wed, Jan 11, 2012 • 6 Comments
Generex Corporate Update: The Potential Is There
VFC's Stock House • Thu, Aug 4, 2011 • 5 Comments
Generex to Spin Off Antigen Express to Unlock True Value
Rich Steffens • Mon, Apr 4, 2011 • 21 Comments
Generex: Raising Cash, But No Oral-lyn Update
VFC's Stock House • Thu, Jan 27, 2011 • 26 Comments
Talking Big Pharma, Vaccines and Baseball With Generex's Dr. Eric von Hofe
Rich Steffens • Thu, Oct 28, 2010 • 14 Comments
Why I Am Voting for Generex's Reverse Stock Split
Rich Steffens • Sat, Oct 16, 2010 • 71 Comments
Generex 's Acquisition Into the Direct to Consumer Diabetes Market Provides Synergistic Value
Rich Steffens • Tue, Oct 12, 2010 • 46 Comments
Generex: Do Development Drug Companies Have No Value?
Thomas Barnard • Mon, Sep 27, 2010 • 51 Comments
News Next Week for Generex May Reduce Need for Reverse Split
Thomas Barnard • Thu, Sep 16, 2010 • 15 Comments
Generex: Reverse Split Not Approved
Thomas Barnard • Sun, Aug 1, 2010 • 25 Comments
Generex's Insulin Product: When a Company Misrepresents 'Compassionate Use'
Derek Lowe • Thu, Apr 29, 2010 • 20 Comments
Generex and Its Insulin Spray: Just Hype?
Derek Lowe • Wed, Apr 7, 2010 • 39 Comments
Generex Is Granted a China Patent for Cancer Vaccine
ChinaBio Today • Wed, Mar 3, 2010
A N.I.C.E. Development for Generex Oral-lyn in the U.K.
Rich Steffens • Sun, Oct 18, 2009 • 2 Comments
Can Generex Biotech Add to Recent Gains?
Trade Radar Operator • Tue, Dec 4, 2007
Generex To Test Cancer Vaccine in China
ChinaBio Today • Wed, Oct 10, 2007 • 2 Comments
Generex Vaccine Shows Anti-Tumor Activity
H.S. Ayoub • Tue, Oct 3, 2006

4 Drug Delivery Companies That Deliver For Investors
Ryan's View • Wed, Feb 27
Weekly Stock Watch: Week Of July 9
VFC's Stock House • Sun, Jul 8, 2012
Critical Success Factors For The Immunotherapy Race
Andrew J. Norris • Thu, May 17, 2012 • 9 Comments
Breast Cancer Immunotherapy: A New Hope In The Fight
Chemistfrog • Fri, Mar 9, 2012 • 17 Comments
Financing Deals Sent Shares Of These 3 Companies South
VFC's Stock House • Wed, Feb 1, 2012 • 3 Comments
Biopharma Stocks To Watch This Week
VFC's Stock House • Thu, Jan 19, 2012 • 1 Comment
2012 Preview: Cancer Immunotherapy Catalysts
Michael Becker • Thu, Dec 15, 2011 • 20 Comments
Stocks To Watch As Volatility Abounds In Europe
VFC's Stock House • Wed, Nov 16, 2011 • 3 Comments
Mannkind: One To Watch With High Short Interest And Insider Buying
VFC's Stock House • Mon, Nov 14, 2011 • 8 Comments
Weekly Healthcare Stock Watch
VFC's Stock House • Wed, Oct 5, 2011
Stocks to Watch This Week
VFC's Stock House • Mon, Jun 13, 2011 • 9 Comments
Filling an Unmet Need: A Look at Generex and RXI Pharma's Breast Cancer Vaccines
Rich Steffens • Thu, Jun 2, 2011 • 6 Comments
A Simplified ASCO 2011 List for Biotech Investor Research
Chemistfrog • Mon, May 9, 2011 • 2 Comments
Mannkind/Generex: Both on the Brink of Diabetic Insulin Spray Breakthrough
VFC's Stock House • Fri, May 6, 2011 • 16 Comments
Mannkind Denied Again by FDA; Investors Should Consider Generex
VFC's Stock House • Wed, Apr 13, 2011 • 15 Comments
Mannkind: Denied Yet Again
VFC's Stock House • Thu, Jan 20, 2011 • 18 Comments
Generex Taps Former Eli Lilly Medical Director to Strengthen Clinical and Regulatory Efforts
Rich Steffens • Fri, Dec 10, 2010 • 26 Comments
Analyzing Generex and Throwing Darts With Pfizer's Craig Eagle
Rich Steffens • Wed, Aug 25, 2010 • 20 Comments
Good News for Generex: Positive Data on Oral Insulin Coming in September
Rich Steffens • Mon, Aug 16, 2010 • 29 Comments
Four Small Caps for Binary Event Investors
Mike Havrilla • Mon, May 24, 2010

Generex Biotechnology's CEO Hosts Investor Conference Call (Transcript)
Thu, Jan 31 • 1 Comment

Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine

PR Newswire (Wed, 9:00AM)
Generex Comments on Results of Stockholders` Meeting

PR Newswire (Apr 3, 2013)

GNBT.OB vs. ETF Alternatives

Company Description

We were incorporated in Delaware in September 1997 for the purpose of acquiring Generex Pharmaceuticals Inc., a Canadian corporation formed in November 1995 to engage in pharmaceutical and biotechnological research and development and other activities. Our acquisition of Generex Pharmaceuticals... More

Sector: Healthcare

Industry: Drug Delivery & Accessories

Country: Canada

All
| Earnings
| Dividends
| M&A
| On the move

Monday, October 18, 2010, 9:00 AM Premarket gainers: KWK +15%. ISTA +15%. PPHM +9%. GNBT +8%. STX +6%. FBP +6%. STEM +6%. AGN +5%. PIP +5%.
Losers: PETS -13%. MMR -4%. Comment!
Friday, March 19, 2010, 9:00 AM Premarket gainers: LYG +10%. LGF +8%. CRBC +8%. GNVC +4%. RBS +4%. BBY +4%. AIB +4%.
Losers: PALM -17%. SPWRA -10%. SB -7%. GNBT -7%. HT -4%. GSL -4%. 1 Comment
Friday, February 26, 2010, 9:00 AM Premarket gainers: CKR +26%. RST +23%. GNBT +8%. AGO +6%. CHU +5%.
Losers: ATHN -11%. NVTL -10%. WTW -10%. CROX -10%. JRCC -9%. LYG -7%. AIG -6%. SD -6%. IRE -6%. FLR -5%. LYV -5%. TKC -4%. Comment!
Monday, February 1, 2010, 9:00 AM Premarket gainers: ALV +7%. DDSS +6%. CRNT +6%. IOC +5%. ERIC +4%.
Losers: EBR -20%. SOHU -8%. GNBT -6%. Comment!
Tuesday, January 19, 2010, 9:00 AM Premarket gainers: CFL +32%. GNVC +16%. TGB +14%. KEP +12%. NLST +10%. WMB +8%. DSCO +8%. TSEM +6%. CIEN +6%. CBY +5%. GNBT +5%. PH +5%. AVII +4%.
Losers: ETFC -4%. Comment!
Thursday, January 14, 2010, 9:00 AM Premarket gainers: LAB +46%. TSTR +16%. AONE +11%. HNSN +10%. SATC +9%. DPZ +5%. CPBY +5%. GNBT +4%.
Losers: CTIC -10%. MED -9%. KYN -7%. SEED -6%. NBG -4%. IRE -4%. YRCW -4%. AMX -4%. Comment!
Wednesday, October 21, 2009, 9:00 AM Premarket gainers: SLM +11%. SNDK +5%. YHOO +5%. ELN +4%.
Losers: AGEN -41%. TSFG -23%. PLCM -13%. ATI -7%. KEY -4%. GNBT -4%. STM -4%. BEE -4%. 1 Comment
Thursday, October 15, 2009, 9:00 AM Premarket gainers: ACOR +51%. CIT +11%. PLX +7%. HEB +4%. TSEM +4%.
Losers: MNI -15%. NOK -8%. GNBT -7%. AIB -5%. AIXG -5%. COF -5%. IRE -4%. LVS -4%. GFI -4%. HOG -4%. Comment!
Thursday, September 10, 2009, 11:29 AM Generex (GNBT +28%) is up strongly after the FDA said earlier this morning it will allow patients with serious or life-threatening diabetes to use its yet-unapproved orally-administered insulin product Oral-lyn. (PR) Comment!
Tuesday, September 1, 2009, 9:00 AM Premarket gainers: NVAX +14%. YRCW +13%. SVA +10%. BONU +9%. BEXP +7%. TXT +6%. HLCS +5%. ALD +5%. GNBT +4%. INO +4%.
Losers: BEAT -12%. CMED +12%. RMBS -10%. SQNM -9%. IMMU -6%. AXL -6%. CTIC -5%. AIG -5%. CIT -5%. HCN -5%. BVF -4%. Comment!
Thursday, August 27, 2009, 9:00 AM Premarket gainers: IMMU +70%. AIG +10%. AIB +8%. BA +6%. CLNE +6%. VIP +5%. GNBT +4%. CHU +4%. NOK +4%.
Losers: WAVE -18%. APWR -11%. SIGM -10%. ENER -5%. HGSI -4%. Comment!
Monday, June 15, 2009, 9:00 AM Premarket gainers: BDSI +24%. HBAN +13%. CTIC +9%. IMMU +7%. HEB +4%. TQNT +4%.
Losers: GNBT -11%. IRE -9%. LNC -8%. AAV -7%. AIB -7%. LEA -7%. CENX -6%. RTP -6%. STM -6%. TGB -6%. SAY -5%. ESLR -5%. CIT -5%. MT -4%. JASO -4%. Comment!
Friday, June 5, 2009, 9:00 AM Premarket gainers: GNBT +21%. HEB +16%. SOL +10%. XOMA +9%. RTP +9%. FLIR +9%. RAD +8%. AIB +8%. CSUN +8%. BHP +7%. CENX +7%. CRBC +7%. ING +7%. JASO +6%. CLF +6%. PMI +6%. GES +6%. SOLF +6%. CIT +5%. VALE +5%. KEY +5%. GNW +4%. FRO +4%. AIG +4%. DPTR +4%. FEED +4%. LDK +4%. CNB +4%. YGE +4%. AMD +4%. PCX +4%. Comment!

0123456789
GNBT.OB Antigen Express produces a little hype: http://on.fb.me/JnlX6k
5/18/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

FFMJR
GNBT.OB Strategic Plan ???
3/30/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
GNBT.OB has a press conference on Weds. Too many past disappointments to number. Will they finally come through with the goods this time?
3/28/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
MNKD received its expected CRL. Despite happy talk from proponents, this means one more year of delay, minimum. The door is open for GNBT.OB.
1/20/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
I have now eaten every word of my baseless double prediction for GNBT.OB. Their "material announcement" was a sad farce.
10/11/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
My money is on a double in the price of GNBT.OB tomorrow. They announced a material announcement before the open on Monday.
10/10/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
Rx Investors' Cancer Vax Index ==> BPAX, BVTI, CLDX, DNDN, GNBT.OB, NWBO, VICL, ONTY, TRGNF, OPXA ==> http://bit.ly/bxkxgm/
10/1/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

charger60
Does anyone have a feeling of what this stock price will be if the institute a 10 for 1 reverse split on GNBT.OB.
7/20/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Diversify
Sentiment for GNBT.OB appears to be at a low, so I am expecting a reversal very soon and a move up of at least $0.15.
4/21/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Rafie Trading
GNBT.OB moving up! ...sold GOOG positions...
4/14/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

GNBT.OB Generex Biotechnology Corporation

GNBT.OB

Generex Biotechnology Corporation